mTOR pathway and mTOR inhibitors in cancer therapy:
Gespeichert in:
Format: | Elektronisch E-Book |
---|---|
Sprache: | English |
Veröffentlicht: |
[Totowa, NJ]
Humana Press
2010
|
Schriftenreihe: | Cancer drug discovery and development
|
Schlagworte: | |
Online-Zugang: | UBR01 Volltext |
Beschreibung: | 1 Online-Ressource |
ISBN: | 9781603272704 9781603272711 |
DOI: | 10.1007/978-1-60327-271-1 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV036608533 | ||
003 | DE-604 | ||
005 | 20101007 | ||
007 | cr|uuu---uuuuu | ||
008 | 100810s2010 gw |||| o||u| ||||||eng d | ||
020 | |a 9781603272704 |9 978-1-60327-270-4 | ||
020 | |a 9781603272711 |c Online |9 978-1-60327-271-1 | ||
024 | 7 | |a 10.1007/978-1-60327-271-1 |2 doi | |
035 | |a (OCoLC)724692038 | ||
035 | |a (DE-599)BVBBV036608533 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
044 | |a gw |c XA-DE-BE | ||
049 | |a DE-355 | ||
084 | |a XH 3200 |0 (DE-625)152888:12905 |2 rvk | ||
245 | 1 | 0 | |a mTOR pathway and mTOR inhibitors in cancer therapy |c Vitaly A. Polunovsky ..., eds. |
264 | 1 | |a [Totowa, NJ] |b Humana Press |c 2010 | |
300 | |a 1 Online-Ressource | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Cancer drug discovery and development | |
650 | 0 | 7 | |a Sirolimus |0 (DE-588)4458353-9 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Targeted drug delivery |0 (DE-588)4302415-4 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
689 | 0 | 1 | |a Sirolimus |0 (DE-588)4458353-9 |D s |
689 | 0 | 2 | |a Targeted drug delivery |0 (DE-588)4302415-4 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Polunovsky, Vitaly A. |e Sonstige |4 oth | |
856 | 4 | 0 | |u https://doi.org/10.1007/978-1-60327-271-1 |3 Volltext |
912 | |a ZDB-2-SME | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-020528865 | ||
966 | e | |u https://doi.org/10.1007/978-1-60327-271-1 |l UBR01 |p ZDB-2-SME |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804143213051641856 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV036608533 |
classification_rvk | XH 3200 |
collection | ZDB-2-SME |
ctrlnum | (OCoLC)724692038 (DE-599)BVBBV036608533 |
discipline | Medizin |
doi_str_mv | 10.1007/978-1-60327-271-1 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01567nmm a2200433zc 4500</leader><controlfield tag="001">BV036608533</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20101007 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">100810s2010 gw |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781603272704</subfield><subfield code="9">978-1-60327-270-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781603272711</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-60327-271-1</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-60327-271-1</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)724692038</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV036608533</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3200</subfield><subfield code="0">(DE-625)152888:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">mTOR pathway and mTOR inhibitors in cancer therapy</subfield><subfield code="c">Vitaly A. Polunovsky ..., eds.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[Totowa, NJ]</subfield><subfield code="b">Humana Press</subfield><subfield code="c">2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Cancer drug discovery and development</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Sirolimus</subfield><subfield code="0">(DE-588)4458353-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Targeted drug delivery</subfield><subfield code="0">(DE-588)4302415-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Sirolimus</subfield><subfield code="0">(DE-588)4458353-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Targeted drug delivery</subfield><subfield code="0">(DE-588)4302415-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Polunovsky, Vitaly A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-60327-271-1</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-020528865</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-60327-271-1</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV036608533 |
illustrated | Not Illustrated |
indexdate | 2024-07-09T22:44:05Z |
institution | BVB |
isbn | 9781603272704 9781603272711 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-020528865 |
oclc_num | 724692038 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource |
psigel | ZDB-2-SME |
publishDate | 2010 |
publishDateSearch | 2010 |
publishDateSort | 2010 |
publisher | Humana Press |
record_format | marc |
series2 | Cancer drug discovery and development |
spelling | mTOR pathway and mTOR inhibitors in cancer therapy Vitaly A. Polunovsky ..., eds. [Totowa, NJ] Humana Press 2010 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Cancer drug discovery and development Sirolimus (DE-588)4458353-9 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Targeted drug delivery (DE-588)4302415-4 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 s Sirolimus (DE-588)4458353-9 s Targeted drug delivery (DE-588)4302415-4 s DE-604 Polunovsky, Vitaly A. Sonstige oth https://doi.org/10.1007/978-1-60327-271-1 Volltext |
spellingShingle | mTOR pathway and mTOR inhibitors in cancer therapy Sirolimus (DE-588)4458353-9 gnd Krebs Medizin (DE-588)4073781-0 gnd Targeted drug delivery (DE-588)4302415-4 gnd |
subject_GND | (DE-588)4458353-9 (DE-588)4073781-0 (DE-588)4302415-4 |
title | mTOR pathway and mTOR inhibitors in cancer therapy |
title_auth | mTOR pathway and mTOR inhibitors in cancer therapy |
title_exact_search | mTOR pathway and mTOR inhibitors in cancer therapy |
title_full | mTOR pathway and mTOR inhibitors in cancer therapy Vitaly A. Polunovsky ..., eds. |
title_fullStr | mTOR pathway and mTOR inhibitors in cancer therapy Vitaly A. Polunovsky ..., eds. |
title_full_unstemmed | mTOR pathway and mTOR inhibitors in cancer therapy Vitaly A. Polunovsky ..., eds. |
title_short | mTOR pathway and mTOR inhibitors in cancer therapy |
title_sort | mtor pathway and mtor inhibitors in cancer therapy |
topic | Sirolimus (DE-588)4458353-9 gnd Krebs Medizin (DE-588)4073781-0 gnd Targeted drug delivery (DE-588)4302415-4 gnd |
topic_facet | Sirolimus Krebs Medizin Targeted drug delivery |
url | https://doi.org/10.1007/978-1-60327-271-1 |
work_keys_str_mv | AT polunovskyvitalya mtorpathwayandmtorinhibitorsincancertherapy |